CCND1 and breast cancer: Overall, the positive ratio of expression of CDK2-AP1 was reduced successively in normal breast tissue, DCIS, invasive breast cancer and relapsed breast cancer, in contrast to CDK2 and CyclinD1 expression (Table 1, Figure 1).